The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...

Shares of Moderna surged to lead S&P 500 gainers in early afternoon trading Tuesday, hours after the Food and Drug ...

According to a Moderna statement, the booster stimulated a greater than ... still ongoing however about the possibility of offering a fourth shot more widely to protect against a resurgence ...

The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines to that age group at least four months after their previous booster. Until now, the FDA had ...

Moderna, Inc. (NASDAQ:MRNA) shares soared to the top of the S&P 500 gainers in early afternoon trading on May 20, surging by ...

According to specialists, in the fourth dose, Minsa had to administer 50 micrograms of the product, however, twice as much (100 micrograms) was used when placing the booster with the Moderna ...

With COVID-19 vaccinations ramping up to a fourth dose ... the J&J vaccine and a J&J booster. This improved defense also appears to work with mixing and matching Moderna and Pfizer boosters ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

It looked at differences between patients given a Moderna booster after having had two jabs of the Pfizer vaccine and those who received the Pfizer vaccine three times. While about 70 percent of ...

Allowing the opportunity to strengthen the immunization of those vaccinated for COVID-19 over six months, the Food and Drug Administration approved booster shots of the Moderna vaccine and Johnson & ...

The European Medicines Agency (EMA) has concluded that a booster shot of the Pfizer/BioNTech and Moderna coronavirus vaccines “may be given to people with severely weakened immune systems, at least 28 ...